Cutler Group LP Protalix Bio Therapeutics, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$0.81 - $1.17 $8,154 - $11,778	-10,067 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$0.81 - $1.33 $972 - $1,596	-1,200 Reduced 10.65%	10,067 $8,000
Q3 2021 Oct 26, 2021	BUY	$1.31 - $1.87 $5,720 - $8,166	4,367 Added 63.29%	11,267 $14,000
Q2 2021 Jul 19, 2021	BUY	$1.86 - $6.22 $12,834 - $42,918	6,900 New	6,900 $13,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.